Profile picture

Doctor Jihun Ahn

Soon Chun Hyang University Gumi Hospital, Gumi (Korea (Republic of))
Follow
Logo ESC

Contributor content

Impact of systolic dysfunction and elevated left ventricular end diastolic pressure on three years clinical outcome in patients with atrial fibrillation
Presentation
Impact of systolic dysfunction and elevated left ventricular end diastolic pressure on three years clinical outcome in patients with atrial fibrillation
One year follow-up of primary stenting and standard balloon angioplasty for the below-knee arterial in patients underwent percutaneous transluminal angioplasty
Presentation
One year follow-up of primary stenting and standard balloon angioplasty for the below-knee arterial in patients underwent percutaneous transluminal angioplasty
Predictive value of echocardiographic measurement for evaluating diastolic dysfunction in chronic atrial fibrillation patients with preserved left ventricular ejection fraction
Presentation
Predictive value of echocardiographic measurement for evaluating diastolic dysfunction in chronic atrial fibrillation patients with preserved left ventricular ejection fraction
Comparison of dual drug-eluting (CILOTAXTM) and everolimus-eluting stents in patients with ST-elevation myocardial infarction (STEMI); 3-years clinical outcomes
Presentation
Comparison of dual drug-eluting (CILOTAXTM) and everolimus-eluting stents in patients with ST-elevation myocardial infarction (STEMI); 3-years clinical outcomes
Predictive value of echocardiographic measurement for evaluating left ventricular filling pressure in chronic atrial fibrillation patients with preserved left ventricular ejection fraction
Presentation
Predictive value of echocardiographic measurement for evaluating left ventricular filling pressure in chronic atrial fibrillation patients with preserved left ventricular ejection fraction
Paclitaxel- versus zotarolimus-eluting stents in diffuse coronary artery disease; 3-year clinical cutcomes
Presentation
Paclitaxel- versus zotarolimus-eluting stents in diffuse coronary artery disease; 3-year clinical cutcomes

ESC 365 is supported by